Sun Genomics will present at the Microbiome R&D and Business Collaboration Forum in San Diego

News and research before you hear about it on CNBC and others. Claim your one week free trial for StreetInsider Premium here.

SAN DIEGO, March 23, 2022 (GLOBE NEWSWIRE) — Sun Genomics, creator of Floré, the world’s only fully personalized precision probiotic, today announced that its Founder and CEO, Sunny Jain, will deliver a keynote address at the 9th Annual Microbiome R&D and Business Collaboration Forum, which will take place on March 29 and 30, 2022 in San Diego. Jain will present work from Sun Genomics related to chronic disease, while Diana C. Calvo, postdoctoral associate at the Biodesign Center for Health Through Microbiomes at Arizona State University (ASU), will present the link between dysbiotic gut microbiota and autism. .

Jain’s keynote presentation, titled “Long-Term Precision Probiotics and Diversity in People with IBS,” focuses on the importance of metagenomics and why precision is a fundamental factor in understanding stratified disease patterns.

Dr. Calvo’s presentation, titled “Can Altering the Gut Bacterial Community Improve Gastrointestinal and Autistic Symptoms?” focuses on whether modifying the gut microbiota in children with autism can improve gastrointestinal and behavioral symptoms. The Biodesign Center for Health Through Microbiomes launched a clinical trial of microbiota transfer therapy (MTT) for autism, and participants responded to treatment with rapid improvements in gastrointestinal and behavioral symptoms. Today, in collaboration with Sun Genomics, the Biodesign Center for Health Through Microbiomes is working on a new approach to modify the gut microbiota through personalized probiotics. Together, the two are gathering gastrointestinal symptoms, behavioral phenotypes, and gut microbiome data from 315 children diagnosed with autism to analyze the effects of probiotic therapy on the gut microbiome.

“Presenting with Dr. Calvo at the prestigious Microbiome R&D and Business Collaboration Forum will draw increased attention to the clinical value of probiotics and the link between the gut microbiome and autism symptoms,” said Jain. . “We are honored to have the opportunity to assist ASU with the world’s largest metagenomic research study of autism spectrum disorders and to uncover new insights regarding the impact of probiotics. Ultimately, our goal is to help improve people’s lives.

Dedicated to exploring microbiome research and commercialization and product development strategies, the Microbiome R&D and Business Collaboration Forum brings together key opinion leaders (KOLs) to present a series of R&D case studies on topics related to intestinal health and diseases. The forum is held in conjunction with the 3rd Skin & Cosmeceuticals Congress and the 6th Probiotics & Prebiotics Congress. Attendees can jump between events and have access to 75 presentations.

About Sun GenomicsSun Genomics, headquartered in San Diego, Calif., is a leader in gut health testing. Founded in 2016, the company specializes in tailor-made probiotics based on an individual’s gut microflora. This is determined using a special stool sample test procedure. This approach ensures customers receive a fully personalized probiotic that can be maintained as a subscription.

On Center for Biodesign for Health through MicrobiomesLocated at Arizona State University, the research team is creating foundational knowledge to develop microbe-based health interventions and diagnostics for better human health. Using fundamental knowledge of microbiomes, they develop methods to identify and track gut microbes and their products and develop microbial interventions for better human health.

Media Contact

Janine Warner
Crowe PR
[email protected]
(619) 794-0114, ext. 722

main logo

Source: Sun Genomics